jpm

날짜:

이벤트:

Meet with Novotech at JPM to discuss accelerated FIH pathways, smarter regional strategies, and global execution designed for biotech momentum.

What we offer biotechs: 

Move faster 

  • Start first-in-human (FIH) in Australia without an IND, using established regulatory pathways and experienced local teams.
  • Activate sites quickly in high-performing regions so you can reach decision-making data sooner and avoid slow-start bottlenecks. 

Spend smarter 

  • Tap capital-efficient regions across APAC and China, where startup, monitoring, and enrollment costs can be significantly lower than in traditional markets.
  • Structure studies to balance cost, speed, and quality, ensuring every dollar is focused on reaching your next milestone—not on unnecessary rerouting. 

Scale globally 

  • Integrate North America, Europe, and APAC under one coordinated operating model, with consistent governance and communication.
  • Benefit from transparent delivery and predictable timelines to support board, partner, and investor discussions. 

If your science is ready to move, we’re ready to help you move faster. 

Schedule a meeting with our team.

본 행사는 종료되었습니다.

노보텍에 관심을 가져주셔서 감사합니다. 행사는 종료되었지만, 노보텍의 전문가들은 임상 개발 전 단계에 걸쳐 스폰서를 지속적으로 지원하고 있습니다.

궁금한 점이 있거나 상담이 필요하신가요?

노보텍의 임상 개발 전문가와 상담해 보세요.

Meet Our Team

Novotech

Dr. Judith Ng-Cashin

Novotech
Chief Medical Officer
Novotech

Barry Murphy

Novotech
Chief Commercial Officer
Novotech

Dr. Yooni Kim

Novotech
Chief Customer Experience Officer
Novotech

Michael Stibilj

Novotech
Chief Operating Officer
Novotech

Rick Farris

Novotech
Managing Director, North America
Novotech China

Andy Liu

Novotech China
Managing Director, Greater China & Global Labs Executive
Novotech

Dr. David Ng

Novotech
Vice President of Biometrics

Plus commercial and clinical teams from North America, Europe, and APAC.